MedTrace Logo

Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation

NCT00926315 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-11-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether calcitriol supplementation may reduce tumor cell proliferation and influence gene expression profile of breast cancer samples from post-menopausal patients.

Conditions

  • Breast Neoplasms
  • Postmenopausal Disorder

Interventions

DRUG

calcitriol

Post menopausal patients will receive Calcitriol 0.50 mcg PO per day for 1 month.

DRUG

Calcitriol

calcitriol 0.25 mcg PO bid

Sponsors & Collaborators

  • Instituto Brasileiro de Controle do Cancer

    collaborator OTHER

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Maria Aparecida A Koike Folgueira, MD,PhD · Faculdade de Medicina - Universidade de São Paulo

  • Eduardo Carneiro de Lyra, MD, PhD · Instituto Brasileiro de Controle do Cancer

  • Yuri N Urata, MSc · Faculdade de Medicina da Universidade de São Paulo

  • Maria Lucia H Katayama, PhD · Faculdade de Medicina da Universidade de São Paulo

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2013-06-30
Completion
2013-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926315 on ClinicalTrials.gov